These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3612481)

  • 1. [Fabrication and coating of microgranules of acetylsalicylic acid: use of eudragit L30D].
    Dechesne JP
    J Pharm Belg; 1987; 42(2):85-94. PubMed ID: 3612481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fabrication and coating of microgranules of acetylsalicylic acid: use of HP55].
    Dechesne JP
    J Pharm Belg; 1987; 42(2):95-100. PubMed ID: 3612482
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of traces of organic solvents in microgranules of acetylsalicylic acid coated with HP55].
    Dechesne JP
    J Pharm Belg; 1987; 42(2):135-7. PubMed ID: 3612479
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of Eudragit type on the dissolution rate of acetylsalicylic acid from matrix tablets.
    Jovanović M; Jovicić G; Djurić Z; Agbaba D; Karljiković-Rajić K; Nikolić L; Radovanović J
    Acta Pharm Hung; 1997 Nov; 67(6):229-34. PubMed ID: 9423294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric-coated cholylsarcosine microgranules for the treatment of short bowel syndrome.
    Fürst T; Bott C; Stein J; Dressman JB
    J Pharm Pharmacol; 2005 Jan; 57(1):53-60. PubMed ID: 15638993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid state stability of acetylsalicylic acid in binary mixtures with microcrystalline and microfine cellulose.
    Ahlneck C; Alderborn G
    Acta Pharm Suec; 1988; 25(1):41-52. PubMed ID: 3414383
    [No Abstract]   [Full Text] [Related]  

  • 9. [The texture and properties of acetylsalicylic acid tablets. 1. The effect of manufacturing methods on the properties of tablets].
    Nagy G; Keresztes A; Pintye-Hódi K; Selmeczi B; Kedvessy G
    Pharmazie; 1978 Nov; 33(11):747-9. PubMed ID: 751075
    [No Abstract]   [Full Text] [Related]  

  • 10. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of 4 formulation factors on the release of indomethacin from inert matrices with a Eudragit base].
    Gueurten D
    Pharm Acta Helv; 1984; 59(7):200-4. PubMed ID: 6473479
    [No Abstract]   [Full Text] [Related]  

  • 12. Citric acid as a solid-state plasticizer for Eudragit RS PO.
    Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
    J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stabilization of acetylsalicylic acid in solid drug form. II. Influence of coating technic and coating material on some properties of coated acetylsalicylic acid and tablets made thereof].
    Stozek T; Krówczyński L
    Acta Pol Pharm; 1973; 30(4):409-18. PubMed ID: 4762337
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternative method for enteric coating of HPMC capsules resulting in ready-to-use enteric-coated capsules.
    Huyghebaert N; Vermeire A; Remon JP
    Eur J Pharm Sci; 2004 Apr; 21(5):617-23. PubMed ID: 15066662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
    Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiinflammatory activities of polymers of o-metacryloyloxybenzoic acid.
    Grimová J; Hrabák F
    J Biomed Mater Res; 1978 Jul; 12(4):525-30. PubMed ID: 681371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: The interaction of preservatives with polyHEMA.
    Richardson NE; Meakin BJ; Davies DJ
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():26P. PubMed ID: 2699
    [No Abstract]   [Full Text] [Related]  

  • 19. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
    Ruckmani K; Muneera MS; Vijaya R
    Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an enteric-coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis.
    Huyghebaert N; Vermeire A; Rottiers P; Remaut E; Remon JP
    Eur J Pharm Biopharm; 2005 Oct; 61(3):134-41. PubMed ID: 15967652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.